MedPath

Supporting Attendance for Facility Delivery and Infant Health

Not Applicable
Completed
Conditions
AIDS
HIV
Interventions
Behavioral: Transport Payments
Behavioral: mHealth messaging
Registration Number
NCT03023033
Lead Sponsor
Elizabeth Glaser Pediatric AIDS Foundation
Brief Summary

The goal of this proposed intervention study is to increase the proportion of HIV positive and HIV negative pregnant women who deliver in a facility, the proportion of HIV exposed infants (HEI) who receive nevirapine (NVP) within 48 hours of delivery, and the proportion of HEI who are bled for HIV polymerase chain reaction (PCR) deoxyribonucleic acid (DNA) testing within 8 weeks of age.

Detailed Description

Following a formative phase I, we propose in phase II to implement a three-group cluster-randomized study to test the effectiveness of short message service (SMS) reminders and notifications, \[mobile health or mhealth\] (group 1) and the combined effectiveness of SMS reminders/notifications and cash transfers (group 2) compared to the standard prevention of mother-to-child transmission (of HIV)/maternal, neonatal and child health, (PMTCT/MNCH) practices (group 3).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1505
Inclusion Criteria
  • Known or recently diagnosed HIV-positive in ANC or; Tested HIV-negative at ANC
  • Plans to deliver in facility catchment area
  • 18 years or older
  • Able and willing to provide consent
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Clinic group 2Transport PaymentsClinics using SMS health promotion and reminder messages + Clinics providing payment scaled to reflect typical transport costs to facility (transport payments)
Clinic group 1mHealth messagingClinics using SMS health promotion and reminder messages (mhealth messaging)
Primary Outcome Measures
NameTimeMethod
Early identification of HEI at Reproductive and Child Health (RCH) Clinic1 year

Proportion of HEI identified early (48 hours,3 and 7 days) at RCH clinic

Antenatal care (ANC) visits1 year

Proportion of pregnant women attending at least 4 ANC visits

Facility delivery1 year

Proportion of pregnant women delivering in a health facility

Post natal care (PNC) visits1 year

Proportion of post partum women attending PNC 48 hours, 3 and 7 days post delivery

Nevirapine (NVP) at delivery1 year

Proportion of HEI given NVP at delivery

Attendance for Early infant diagnosis (EID) of HIV1 year

Proportion of HIV-exposed infants (HEI) attending for early infant diagnosis of HIV (DBS collected) by 8 weeks

Secondary Outcome Measures
NameTimeMethod
Receipt of EID results1 year

Proportion of HEI who received EID results by 12 weeks

Time to receipt of EID results1 year

Time (days/weeks) from date of birth to receipt of EID results

Time to treatment! year

Time (days/weeks) from date of birth to initiation of ART

HIV infected infants initiated on antiretroviral therapy (ART)1 year

Proportion of HIV infected infants initiated on ART by 12 weeks of age

Time to EID1 year

Time (days/weeks) from date of birth to attendance for EID

Trial Locations

Locations (1)

Elizabeth Glaser Pediatric AIDS Foundation

🇹🇿

Dar es Salaam, Tanzania

© Copyright 2025. All Rights Reserved by MedPath